The c.1130C>T variant in MYOC is a missense variant predicted to cause substitution of Threonine by Methionine at amino acid 377 (p.Thr377Met). The highest minor allele frequency of this variant was in the African/African American genetic ancestry group of gnomAD (v4.1.0) = 0.00002668 (2 alleles out of 74,972), which met the ≤ 0.0001 threshold set for PM2_Supporting in a genetic ancestry group of at least 10,000 alleles. The REVEL score = 0.924, which was within the 0.773-0.931 range for PP3_Moderate, predicting a damaging effect on MYOC function. The Thr377Met protein had increased instability levels compared to wild type myocilin protein in these studies (PMIDs: 21612213, 23129764). The assays met the OddsPath threshold for PS3_Moderate (> 4.3) indicating that this variant did impact protein function. The assays reporting solubility and secretion evidence (PMIDs: 11004290, 10545602, 16297911, 16466712) indicated that this variant may impact protein solubility and secretion, however, as the results were conflicting and inconclusive, this evidence was not included. 47 segregations in 6 families, with juvenile or primary open angle glaucoma (JOAG or POAG), have been reported (PMIDs: 20390039, 11004290, 28564705, 15823921, 12912696), which fulfilled PP1_Strong (≥7 meioses in >1 family). There were more family studies published than presented here. 15 probands with JOAG or POAG have been reported carrying this variant (PMIDs: 28564705, 22933836, 11004290, 12868033, 20390039, 14627955, 10196380, 15823921, 12912696), which met PS4 (≥ 15 probands). There were more probands published than presented here. Another missense variant (c.1130C>A, p.Thr377Lys, Grantham score = 78, ClinVar ID: 2500837) at the same codon has been classified as likely pathogenic for juvenile open angle glaucoma by the ClinGen Glaucoma VCEP. The c.1130C>T, p.Thr377Met variant has a higher Grantham score (= 81) than the previously classified amino acid change, was not predicted to affect splicing as assessed with SpliceAI (≤ 0.2), and met PP3, meeting the conditions for PM5_Supporting to apply. In summary, this variant met the criteria to receive a score of 14 and to be classified as pathogenic (pathogenic classification ≥ 10, adapted from PMID: 32720330) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v2.0.0, 5 Dec 2024): PS4, PP1_Strong, PS3_Moderate, PP3_Moderate, PM2_Supporting, PM5_Supporting